Baxter International, Inc.

843 articles with Baxter International, Inc.

• Baxter to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

  10/15/2020

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference via webcast on Monday, November 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 11:45 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Nov

• Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care

  10/14/2020

  Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care Study is first to demonstrate importance of using indirect calorimetry (IC) to measure variable and dynamic energy needs of COVID-19 patients in the intensive care unit Data gathered from Q-NRG+ metabolic monitor device shows variance in resting energy expenditure (REE) measurements in comparison to frequently uti

•  Baxter Announces U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition

  9/23/2020

    Baxter Announces U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition   New formulations provide up to 60% more protein (amino acid) than current Clinimix formulations while delivering less dextrose 1

• Baxter Announces Exclusive Distribution Agreement With bioMérieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.

  9/16/2020

  Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced a distribution agreement with bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, for the NEPHROCLEARTM CCL14 diagnostic test.

• CORRECTING and REPLACING Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors

  9/9/2020

  Baxter International Inc., a leading global medical products company, will host a conference call to discuss its third-quarter 2020 financial results on Thursday, October 29, 2020, at 7:30 a.m. Central Time.

• Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors

  9/9/2020

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2020 financial results on Thursday, October 29, 2020, at 7:30 a.m. Central Time.

• Baxter Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy

  8/31/2020

  U.S. patients with kidney failure now have access to expanded hemodialysis (HDx) therapy delivered by Theranova, a new class of dialyzer Theranova dialyzer’s unique membrane design offers a filtration profile that more closely mimics that of the natural kidney and can be used with existing hemodialysis machines 1,2 Theranova was reviewed by FDA through the De Novo process, a pathway for novel low- to moderate-risk devices

• Baxter to Present at the Virtual Morgan Stanley 18th Annual Global Healthcare Conference

  8/20/2020

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the virtual Morgan Stanley 18 th Annual Global Healthcare Conference via webcast on Wednesday, September 16, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 12:30 p.m. Eastern Time. The live webcast

• Baxter to Present at the 2020 Wells Fargo Virtual Healthcare Conference

  8/19/2020

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2020 Wells Fargo Virtual Healthcare Conference via webcast on Wednesday, September 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through October

• Baxter Obtains U.S. FDA Emergency Use Authorization for Regiocit Replacement Solution Used in CRRT

  8/14/2020

  Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for Regiocit, the company’s replacement solution that contains citrate for regional citrate anticoagulation of the extracorporeal circuit.

• Baxter Obtains U.S. FDA Emergency Use Authorizations for HF20 Set and ST Set Used in CRRT During Covid-19 Pandemic

  8/12/2020

  Provides additional options to help meet increased demand for continuous renal replacement therapy (CRRT) products resulting from COVID-19 pandemic Most recent example of Baxter’s efforts to increase supply of dialysis products used in an acute care environment DEERFIELD, Ill.--( BUSINESS WIRE )-- Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the U.S.

• Baxter Introduces Virtual Peritoneal Dialysis Excellence Academy for Nurses in the U.S.

  8/5/2020

  First-of-its-kind curriculum educates peritoneal dialysis (PD) nurses in one easily accessible resource Learners earn continuing education (CE) credits and expand knowledge on PD management best practices Trainings offered in interactive, on-demand, and self-guided formats

• Baxter Reports Second-Quarter 2020 Results

  7/30/2020

  Second-quarter revenue of $2.7 billion decreased 4% on a reported basis, 1% on a constant currency basis and 2% on an operational basis1

• Baxter and Ayogo Announce Partnership for Unique Digital Health Solutions for Home Dialysis

  7/29/2020

  Companies forge exclusive partnership to advance digital health solutions that educate and empower patients with kidney failure The companies’ first mobile app, CKD&Me , launched in the United States; now preparing for global expansion Collaboration expected to also bring new patient mobile capabilities to Baxter’s Sharesource telehealth platform to support patient engagement and therapy management DEERFIELD, Ill. &

• Baxter and VIPUN Medical Announce Collaboration to Commercialize Innovative Gastric Monitoring System to Help Enhance Clinical Nutrition

  7/24/2020

  Innovative system measures stomach motility to help clinicians identify enteral feeding intolerance Technology designed to help address malnutrition in the ICU and support clinical decision-making Baxter gains exclusive distribution rights to bring system to clinicians worldwide

• Baxter Ranks in Top 10% on 2020 Disability Equality Index

  7/15/2020

  Baxter International Inc., a leading global medical products company, announced it has been named a top-scoring company on the 2020 Disability Equality Index® by Disability:IN, the leading nonprofit resource for business disability inclusion worldwide.

• Baxter Declares Quarterly Dividend - July 14, 2020

  7/14/2020

  Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of $0.245 per share of common stock.

• Baxter to Host Second-Quarter 2020 Financial Results Conference Call for Investors

  7/9/2020

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its second-quarter 2020 financial results on Thursday, July 30, 2020, at 7:30 a.m. Central Time.

• Baxter Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery

  7/9/2020

  Designed to enhance bone growth and help achieve fusion in surgeries involving the skeletal system Recent study shows posterolateral fusion success associated with improved patient outcomes, including reduced pain from baseline New configurations give surgeons versatile options that are easy to mold DEERFIELD, Ill.--( BUSINESS WIRE )-- Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today

• Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen

  6/25/2020

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2019 Corporate Responsibility Report . The report, published annually, details progress towards realizing the company’s Corporate Responsibility priorities and goal